Introduction: Neurosurgery is an important element of brain tumour treatment but carries with it the risk of complications. Previous work has defined a narrow set of general post-operative complications which are used as Patient Safety Indicators (PSIs), but these are not brain tumour specific and do not capture the full range of complications. As a result, there is no way of measuring post-operative complications in neurosurgery at a national level.
Methods: We conducted a retrospective, observational cohort study using a comprehensive national administrative dataset from England on adult brain or spinal tumour patients to better define post-operative complications. We generated and validated a new list of post-operative complications - ICL list. The ICL list contains codes selected specifically from our Gliocova dataset combined with general OECD-defined PSI list. The ICL list is novel as it can assess brain tumour patient complications using an administrative dataset at a national level and captures more specific brain tumour related complications.
Results: In our study, 30-day readmission after surgery was 12.7% and 30-day mortality was 2.3%. The ICL list of complications identified many more patients with complications (N = 3,274 (11.3%)) compared to OECD-defined PSI list (N = 568 (2.0%)) without reducing model performance. 30-day mortality was 6.5% in those with complications and 1.8% in those without.
Discussion: We have identified a much wider set of complications than the OECD-defined PSIs and shown that patients developing these have worse outcomes than those without complications. This enables us to estimate the risk of post-operative complications in brain tumour patients using national administrative data. It forms the basis for planned further work, allowing us to explore the predictors of and consequences of post-operative complications.
Copyright: © 2026 Mauricaite et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.